BSX vs AXNX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BSX Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boston Scientific Corp. (BSX) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, BSX trades at 13.4x Forward P/E with 19.6% operating margin (+1.4% YoY revenue) versus AXNX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BSX sits in CONSOLIDATION (51st %ile IV; Dealer Gamma Walls on Pro) against AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BSX | AXNX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.3B | N/A | Larger Scale | BSX |
| Trailing P/E Ratio Valuation | 18.1x | N/M | Lower Multiple | BSX |
| Forward P/E Ratio Valuation | 13.4x | N/M | Lower Multiple | BSX |
| Revenue Growth (YoY) Growth | +1.4% | N/A | Higher Growth | BSX |
| Operating Margin (TTM) Profitability | 19.6% | N/A | Higher Margin | BSX |
| Net Profit Margin Profitability | 16.6% | N/A | Higher Margin | BSX |
| Return on Equity (ROE) Capital Efficiency | 14.1% | N/A | Higher ROE | BSX |
| 52-Week Range Position Momentum | 4% ($40โ$102) | 50% ($0โ$1) | Stronger Trend | AXNX |
| Beta / 30D Volatility Risk Regime | 0.34ฮฒ ยท 43% Vol | N/A | Lower Realized Risk | BSX |
| Unified Institutional Score Composite Signal | 60.6 / 100 (BUY) | 52.1 / 100 (HOLD) | Higher Composite | BSX |